2. UroToday Home
  3. Video Lectures

Advanced Kidney Cancer

The Association Between Depth of Response and Clinical Outcomes in the CheckMate 9ER Trial in Advanced Renal Cell Carcinoma - Andrea Apolo
January 19, 2023
Details
Durvalumab Alone or with Savolitinib or Tremelimumab in Previously Treated Advanced Clear Cell Renal Cancer - CALYPSO Trial Results - Tom Powles
January 4, 2023
Details
The ORACLE Study: The Efficacy of Combination Systemic Therapies in Patients with Non-Clear Cell Renal Cell Carcinoma - Deepak Kilari
January 3, 2023
Details
Predicting Efficacy of Both Nivolumab and of Nivolumab + Ipilimumab in Frontline mccRCC Patients, An Ancillary Analyses from the BIONIKK Randomized Trial - Maxime Meylan
December 6, 2022
Details
Results of a Phase II Randomized Double Blind Trial of PF-04518600, OX40 Antibody, in Combination with Axitinib - Sarmad Sadeghi
October 17, 2022
Details
Clinical Trial Endpoints in the Adjuvant Setting for Renal Cell Carcinoma and Urothelial Cancer - Andrea Apolo and Pavlos Msaouel
October 16, 2022
Details
Belzutifan Plus Cabozantinib Shows Manageable Safety with Promising Antitumor Activity In Treatment-Naïve Advanced Clear Cell RCC, The LITESPARK-003 Study - Toni K. Choueiri
October 16, 2022
Details
Triplet Therapy With Cabozantinib, Nivolumab, and Ipilimumab as First-line Treatment in Patients With Advanced Renal Cell Carcinoma, COSMIC 313 - Toni K. Choueiri
October 3, 2022
Details
Adding Fecal Microbiota Transplantation (FMT) in Combination with Immunotherapy to Treat Renal Cell Carcinoma, The PERFORM Study - Ricardo Fernandes
September 26, 2022
Details
OMNIVORE - Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
September 25, 2022
Details
Final Results of TITAN-RCC Trial - Is a Tailored Approach of Nivolumab and Nivolumab/Ipilimumab as Immunotherapeutic Boost Recommended - Marc-Oliver Grimm
September 22, 2022
Details
Is There Still a Role for Cytoreductive Nephrectomy? Analysis from the CARMENA Trial, Journal Club - Christopher Wallis & Zachary Klaassen
August 30, 2022
Details
The First Neoadjuvant Trial Using Combination Immune Checkpoint Inhibitor and VEGF Inhibitor in Patients With Locally Advanced High-Risk RCC (NeoAvAx) – Axel Bex
May 24, 2022
Details
The Upcoming 2022 European International Kidney Cancer Symposium - Samra Turajlic
April 12, 2022
Details
KEYNOTE-564 30-Month Follow-Up of Pembrolizumab as Post Nephrectomy Adjuvant Therapy for Patients with Renal Cell Carcinoma - Toni Choueiri
March 4, 2022
Details
42-Month Follow-up of KEYNOTE-426, Pembrolizumab plus Axitinib First-Line Treatment for Advanced Renal Cell Carcinoma - Thomas Powles
August 18, 2021
Details
Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma, The CLEAR Trial Journal Club - Christopher Wallis & Zachary Klaassen
August 12, 2021
Details
VEGF Blockade and Combination Therapeutic Options in Advanced Renal Cell Carcinoma - Andrea Apolo
July 8, 2021
Details
ESMO 2020: CheckMate-9ER Study of Nivolumab Combined With Cabozantinib Vs. Sunitinib in Participants With Previously Untreated mRCC - Toni Choueiri
September 28, 2020
Details
Safety and Efficacy of CDX-014, an Antibody-drug Conjugate Directed Against T cell Immunoglobulin Mucin-1 in Advanced Renal Cell Carcinoma - Bradley McGregor
July 29, 2020
Details
Combination Therapies in Metastatic Kidney Cancer - Chung-Han (Joe) Lee
July 7, 2020
Details
Advanced Renal Cell Carcinoma Clinical Research Outcomes and Clinical Implications from ASCO 2020 - Toni Choueiri
June 14, 2020
Details
Immunogenomic Characterization of Advanced Clear Cell Renal Cell Carcinoma Treated with PD-1 Blockade - David Braun
May 30, 2020
Details
OMNIVORE: Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma - Rana McKay
May 30, 2020
Details
KEYNOTE-426: Pembrolizumab plus Axitinib versus Sunitinib as First-Line Therapy for Advanced Renal Cell Carcinoma (RCC) - Brian Rini
May 28, 2020
Details
Frontline Treatment in Advanced Kidney Cancer - Bradley McGregor
March 17, 2020
Details
Atezolizumab and Bevacizumab in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma - Rana Mckay
March 12, 2019
Details
Clinical Trials in Non-clear Cell Kidney Cancer - Darren Feldman
January 15, 2020
Details
Targeted Therapeutic Approaches to Treat Advanced Kidney Cancer - Che-Kai Tsao
January 15, 2020
Details
The Use of Active Surveillance in Metastatic Kidney Disease - Jaime Landman and Monty Pal
December 10, 2019
Details
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic RCC Database Consortium - Shaan Dudani
October 11, 2019
Details
Innovative Research for Advanced Kidney Cancer - David Braun
August 17, 2019
Details
First-line Therapy Options for Metastatic Renal Cell Carcinoma - Tian Zhang
July 13, 2019
Details
The Landscape of Systemic Therapy for Metastatic Renal Cell Carcinoma - Petros Grivas
June 24, 2019
Details
The Dynamic Landscape of mRCC and the PDIGREE Trial - Tian Zhang
June 7, 2019
Details
Newly Approved Treatment Options for the Management of Metastatic Kidney Cancer- Lauren Harshman and Toni Choueiri
June 10, 2019
Details
Targeted Therapies with Immunotherapies In Kidney Cancer - Thomas Powles
April 21, 2019
Details
Rapidly Evolving Landscape in Metastatic Renal Cell Carcinoma- Rana McKay
May 25, 2019
Details
Frontline Data from Keynote 426 - Sandy Srinivas
May 25, 2019
Details
Paradigm Changing Data for Kidney Cancer - Primo Lara
May 24, 2019
Details
Patient Perspectives on Cytoreductive Nephrectomy after the CARMENA Trial - Dena Battle
February 26, 2019
Details
Patient Advocacy and Resources in Kidney Cancer - Dena Battle
February 6, 2019
Details
Monitoring Treatment Toxicities in Patients with Renal Cell Carcinoma: discussion with Dan George and Tian Zhang
November 29, 2018
Details
Evolution of the NCCN Guidelines for Kidney Cancer -Tian Zhang
November 19, 2018
Details
Systemic Therapy Options for Renal Cell Carcinoma - Monty Pal
November 8, 2018
Details
The Use of Molecular Profile in Renal Cancer - Martin Voss
November 6, 2018
Details
ASSET, A Pilot Study Using Exercise Physiology in Advanced Renal Cell Carcinoma - Mike Harrison
October 17, 2018
Details
A Review of Adjuvant Studies in Advanced Renal Cell Carcinoma - Tian Zhang
October 16, 2018
Details
CABOSUN Trial Plus an In-depth Discussion of Kidney Cancer Treatments - Toni Choueiri
October 8, 2018
Details
CARMENA: Practice Changing Strategies for Kidney Cancer
August 30, 2018
Details
email news signup